good try, but no cigar.
Sloppy is launching a trial in a country that they couldn't find people for. 16 people. In a country where there's an apparent market lol
Sloppy is having press releases, trial information, and even its own website being incorrect which I've provided links for. I note Phiefer, who only ever partakes in a slim section of the topic, does not touch the damming stuff and claims victory. Bizzar. All you proved was the flip-flopping sloppiness of CYP.
Sloppy is changing to its 4th country for its lead product, finally going to the US where you all defended not needing to do. Yet here we are.
Sloppy is changing manufactures after commencing your current trials. The FDA won't like that, it's all good now, it's when you have to rely on it for approval after you've spent the money and the time on it.
Sloppy is going to partner everything, then changes to going it alone because you can't find or keep a partner. I recall many here claiming it was the better way, including some very strange analogies, big long-winded speeches from Phiefer. Naturally, we argued against that, yet here we are watching you eat your pie.
Sloopy is claiming better results when more and more information is released, your results were not better. You took the easy way and didn't enroll enough of the sicker grades
You are drinking Nescafe Coffee and we are drinking espresso.
Its been nearly 5 years since the GVHD trial started, 16 people, 28day and 100day primary endpoints. This was the lead product, going at a sloppy, flip-flopping snail pace. By any measure that is ridiculous.
And that's why it's a penny stock. You can't fight me as much as you want but any company that acts like this is going to struggle.
Expand
(20min delay)